Experiencia en el uso de tromboprofilaxis farmacológica en un hospital colombiano de tercer nivel / Experience with the use of pharmacological thromboprophylaxis in a tertiary care Colombian hospital
Acta méd. peru
; 35(2): 108-115, abr. 2018. ilus, tab
Article
em Es
|
LILACS-Express
| LILACS
| ID: biblio-1010896
Biblioteca responsável:
PE1.1
RESUMEN
Objetivo:
Describir las características de la población con patologías no quirúrgicas en quien se indicó manejo de tromboprofilaxis farmacológica en un hospital de tercer nivel y determinar la indicación según riesgo de tromboembolia venosa (VTE) y sangrado con las escalas Padua e IMPROVE Bleeding Score. Materiales ymétodos:
estudio observacional, descriptivo, de corte transversal que incluyó a pacientes > 18 años, con patología no quirúrgica del servicio de medicina interna, con estancia hospitalaria mínima de 48 horas, atendidos entre el 1 de junio de 2015 a 1 de junio de 2016. En la valoración de riesgo de VTE y sangrado se aplicaron las escalas Padua e IMPROVE Bleeding Score, respectivamente.Resultados:
se incluyeron 531 pacientes, de los que el 51,78% fueron hombres, con una edad promedio de 66 años y hospitalización de 37,2 días. La indicación farmacológica más empleada fue la heparina de bajo peso molecular (76,3%). De acuerdo a la escala de Padua, solo 225 pacientes (42,37%) tenían un alto riesgo de tener VTE; según la IMPROVE Bleeding Score, 447 (84,18%) pacientes presentaban bajo riesgo de sangrado y 84 pacientes (15,81%) alto riesgo. Además, se observó que los pacientes con puntaje PADUA ≥ 4, el 21,33% tenía puntaje IMPROVE Bleeding Score ≥7, adicionalmente el 20,23% de los pacientes con alto riesgo de sangrado según esta última escala presentó un episodio de sangrado.Conclusión:
se evidenció un sobreuso de tromboprofilaxis farmacológica, lo cual se ve reflejado en episodios de sangrado en paciente que no tenían indicado su usoABSTRACT
Objective:
To describe the characteristics of the population with non-surgical conditions who were prescribed pharmacological thromboprophylaxis in a tertiary care hospital, and to determine the indication according to the risk for developing venous thromboembolism (VTE) and bleeding using the Padua Scale and the IMPROVE Bleeding Score. Materials andMethods:
This is an observational, descriptive, and cross-sectional study that included patients >18 years old from the internal medicine ward who had no surgical conditions, who were hospitalized for 48 hours as a minimum, between June 1st, 2015 and June 1st, 2016. When assessing the risk for VTE and bleeding the Padua scale and the IMPROVE Bleeding Score were used, respectively.Results:
Five-hundred and thirty-one patients were included, half of them (51.78%) were male, their mean age was 66 years, and their average hospitalization time was 37.2 days. The most frequently used pharmacological indication was low molecular weight heparin (76.3%). According to the Padua scale, only 225 patients (42.37%) were at high risk for developing VTE; according to the IMPROVE Bleeding Score, 447 (84.18%) patients were at low risk for bleeding, and 84 patients (15.81%) were at high risk. Also, it was observed that patients with a >4 score in the PADUA scale, 21.33% had >7 points in the IMPROVE Bleeding Score; additionally, 20.23% of patients at high risk for bleeding according to the latter instrument had a bleeding episode.Conclusion:
There was overuse of pharmacological thromboprophylaxis, which was reflected in the occurrence of bleeding episodes in patients who did not qualify for such indication
Texto completo:
1
Coleções:
01-internacional
Base de dados:
LILACS
Tipo de estudo:
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
País/Região como assunto:
America do sul
/
Colombia
Idioma:
Es
Ano de publicação:
2018
Tipo de documento:
Article